Prescription Drug Misuse in "Clubbers" and Disco Goers in Ibiza. [PDF]
di Giannantonio M +17 more
europepmc +1 more source
Conflict and user involvement in drug misuse treatment decision-making: a qualitative study [PDF]
Jan Fischer +3 more
openalex +1 more source
Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?
British Journal of Clinical Pharmacology, EarlyView.
Christina Gao +3 more
wiley +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Family history of substance problems among African Americans: Associations with drug use, drug use disorder, and prescription drug misuse. [PDF]
Mahrs-Gould R +5 more
europepmc +1 more source
Patterns of Prescription Drug Misuse among Young Injection Drug Users [PDF]
Stephen E. Lankenau +5 more
openalex +1 more source
Attention-Deficit Hyperactivity Disorder Stimulant Therapy and Prescription Drug Misuse During Transition to Young Adulthood. [PDF]
McCabe SE +6 more
europepmc +1 more source
Abstract Guidance from the Department for Education stipulates that permanent exclusions should only be used as a last resort and where there is potential for harm to come to anyone in the school setting. Suspensions are positioned as a tool to communicate to a pupil that their behaviour is in breach of the school's behaviour policy.
Megan Whitehouse
wiley +1 more source
Other Momentary Substance Behaviors as Predictors of College Students' Prescription Drug Misuse in Daily Life: An Exploratory Study. [PDF]
Papp LM, Kouros CD.
europepmc +1 more source

